T. Rowe Price Investment Management
SGRY icon

T. Rowe Price Investment Management’s Surgery Partners SGRY Stock Holding History

T. Rowe Price Investment Management’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.2M Buy
1,949,720
+1,475,397
+311% +$21.2M 0.02% 452
2025
Q4 		$7.33M Sell
474,323
-24,807
-5% -$456K ﹤0.01% 570
2025
Q3 		$10.8M Buy
+499,130
New +$11.1M 0.01% 554
2022
Q4 		– Sell
-1,037,413
Closed -$24.3M – 568
2022
Q3 		$24.3M Buy
+1,037,413
New +$33.1M 0.02% 428

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management's SGRY Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its Surgery Partners (SGRY) stake by 311% in Q1 2026, buying an estimated $21.2M and bringing the position to 1,949,720 shares worth $23.2M. The position accounts for 0.02% of the portfolio, ranked #452.

T. Rowe Price Investment Management first reported a position in SGRY in Q3 2022 and has held it in 4 quarters since. The position peaked at $24.3M in Q3 2022. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • T. Rowe Price Investment Management held 1,949,720 shares of Surgery Partners worth $23.2M as of Q1 2026.
  • T. Rowe Price Investment Management bought 1,475,397 Surgery Partners shares in Q1 2026, an estimated $21.2M.
  • Surgery Partners made up 0.02% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #452 holding.
  • T. Rowe Price Investment Management first reported a position in Surgery Partners in Q3 2022 and has held it in 4 quarters since.
  • T. Rowe Price Investment Management's Surgery Partners position peaked at $24.3M in Q3 2022.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.